The main aim of the conference is to bring together stakeholders from all levels of the health system, from community organisations to health care providers and policy makers to present and discuss new technologies and approaches for integrated testing and linkage to care for HIV, viral hepatitis, sexually transmitted infections (STIs) and tuberculosis (TB), highlighting programmatic and implementation achievements and challenges and adaptation of testing services in response to emerging public health issues, including the ongoing COVID-19 pandemic.

The main objectives of the HepHIV 2021 conference are to:

  1. Exchange lessons learned regarding the impact of COVID-19 on testing and linkage to care services for HIV, viral hepatitis, STIs and TB 
  2. Provide an overview of European level progress at the ’left side’ of the cascade of care (prevention, testing and linkage to care) for HIV, viral hepatitis, STIs and TB 
  3. Share best practices of combination prevention and integrated testing programmes, including innovative/new approaches, and discuss implementation gaps and the use of evidence-based implementation approaches   
  4. Discuss implications for policy and implementation agendas supporting prevention, earlier and integrated testing and linkage care for HIV, viral hepatitis, STIs and TB

The conference will end with a call to action that will address implications for policy and implementation agendas in the field of earlier and integrated testing and will follow up on the HepHIV 2019 conference call to action